Futura Medical PLC (AIM:FUM, OTC:FAMDF), the company behind the sexual health product Eroxon, has just added a new face to its board. Harmesh Suniara has joined as a non-executive director, starting straight away.
Suniara brings more than 17 years of experience in investment management, particularly with UK small and mid-cap companies.
He's been a portfolio manager at Lombard Odier Asset Management since 2017, and before that worked with Henderson Volantis and Gartmore.
It’s worth noting that funds managed by Lombard Odier currently own just over 28% of Futura Medical’s shares, which is nearly 87 million in total.